CKD-841 Pharmacokinetic/Pharmacodynamic Study

NCT03233932 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Postmenopausal Disorder

Interventions

DRUG: LeuplinⓡInj
DRUG: CKD-841

Sponsor

Chong Kun Dang Pharmaceutical

Collaborators

[object Object]